The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
07-Dec-10
$500 million
Target:
Medicity, Inc.
Acquiror:
Aetna Inc.
Advised Aetna Inc. on its acquisition of Medicity, Inc., a leading provider of technology solutions to enable the secure access and exchange of healthcare information
01-Dec-10
$NA
Target:
Planar Solutions, LLC
Acquiror:
FUJIFILM Corporation
Advised Wacker Chemie AG on the sale of Wacker Chemical Corporation’s 50% equity stake in Planar Solutions LLC, a dedicated CMP slurry manufacturer, to its JV partner, FUJIFILM Corporation
12-Jul-10
$NA
Target:
Breast Care Business of Ethicon-Endo Surgery
Acquiror:
Devicor Medical Products, Inc. (a GTCR portfolio company)
Advised GTCR and Devicor Medical Products, Inc., a portfolio company of GTCR, on the acquisition of the Breast Care Business of Ethicon-Endo Surgery
28-Jun-10
$336 million
Target:
Scott Wilson Group plc
Acquiror:
URS Corporation
Advised Scott Wilson Group plc, a LSE listed global integrated design and engineering consultancy, on its sale to URS Corporation, a global provider of engineering, construction and technical services
14-Jun-10
$82 million
Target:
Bemis Company, Inc. (certain of its recently acquired packaging assets)
Acquiror:
Exopack Holding Company
Advised Bemis Company, Inc. on the sale of certain of its recently acquired flexible packaging assets as required by the US Department of Justice as a condition to the closing of its $1.2 billion acquisition of the Alcan Packaging Food Americas business (business unit of Rio Tinto plc)
26-Apr-10
$1.5 billion
Target:
Chloride Group plc
Acquiror:
Emerson Electric Co.
Advised Emerson Electric Co., a diversified global technology and industrial company, on its acquisition of Chloride Group plc, a manufacturer of uninterruptible power supply (UPS) systems
05-Apr-10
$225 million
Target:
Medegen, Inc
Acquiror:
CareFusion Corporation
Advised Medegen, Inc., a medical device company that develops, manufactures and markets clinically superior disposable intravenous therapy products on its sale to CareFusion, a global medical devices company
23-Feb-10
$NA
Target:
Heartscape Technologies, Inc.
Acquiror:
Roper Industries, Inc.
Advised Heartscape Technologies, a medical device company on its sale of substantially all its assets to Roper Industries, a diversified growth company
20-Dec-09
$1.3 billion
Target:
Mining Division of Terex Corp.
Acquiror:
Bucyrus International
Advised Bucyrus International, Inc., a global mining equipment manufacturer, on the acquisition of the mining division of Terex Corp., a diversified equipment company
09-Nov-09
$327 million
Target:
Enzon Pharmaceuticals, Inc.
Acquiror:
Sigma-Tau Pharmaceuticals
Advised Enzon Pharmaceuticals, Inc., a biopharmaceutical company on the sale of its specialty pharmaceutical business to Sigma-Tau, an Italian pharmaceutical company
06-Oct-09
$1.2 billion
Target:
Avocent Corporation
Acquiror:
Emerson Electric Co.
Advised Emerson Electric Co., a diversified global technology and industrial company, on its acquisition of Avocent Corporation, a manufacturer of software and hardware products
05-Jul-09
$1.2 billion
Target:
Alcan Packaging’s Food Americas business (business unit of Rio Tinto plc)
Acquiror:
Bemis Company, Inc.
Advised Bemis Company, Inc., a global supplier of flexible packaging and pressure sensitive materials, on its acquisition of Alcan Packaging’s Food Americas business
23-Jun-09
$155 million
Target:
Monogram Biosciences, Inc.
Acquiror:
Laboratory Corporation of America Holdings
Advised LabCorp on the acquisition of Monogram Biosciences, a molecular diagnostics company focused on guiding and improving the treatment of serious infectious diseases and cancer
12-Mar-09
$46.9 billion
Target:
Genentech, Inc.
Acquiror:
Roche Holding Ltd.
Advised Roche Holding Ltd., a world-leading provider of healthcare pharmaceuticals and diagnostics, on its acquisition of the outstanding publicly held interest in Genentech, Inc., a leading biotechnology company
09-Mar-09
$18.6 billion
Target:
Rohm & Haas Company
Acquiror:
The Dow Chemical Company
Advised The Dow Chemical Company during its negotiations pertaining to the Rohm & Haas settlement resolution
12-Jun-08
$6.7 billion
Target:
Applied Biosystems Group
Acquiror:
Invitrogen Corporation
Provided fairness opinion to the Board of Directors of the Applera Corporation on the merger of its Applied Biosystems business, which serves the life science industry, with the Invitrogen Corporation, creating a global leader in biotechnology reagents and systems
14-Apr-08
$17.7 billion+
Target:
Northwest Airlines
Acquiror:
Delta Air Lines
Advised Delta Air Lines in connection with its merger with Northwest Airlines (+Transaction value represents enterprise value of combined entity)
19-Feb-08
$1.7 billion
Target:
TimberStar Southwest
Acquiror:
Hancock Timber Resource Group
Advised Hancock Timber Resource Group, the largest global timber investment management organization, on its acquisition of TimberStar Southwest, which owns and manages 900,000 acres of timberlands located in Arkansas, Louisiana and Texas
22-Jan-08
$3.4 billion
Target:
Ventana Medical Systems, Inc.
Acquiror:
Roche Holding Ltd.
Advised Roche Holding Ltd., a world-leading provider of healthcare pharmaceuticals and diagnostics, on its acquisition of Ventana Medical Systems, Inc., a US based provider of histopathology diagnostic equipment
13-Aug-07
$185 million
Target:
Central Lewmar LLC
Acquiror:
International Paper Co.
Advised Central Lewmar, a leading distributor of paper and packaging in the United States, on its sale to International Paper’s xpedx distribution business
30-Mar-07
$1.2 billion
Target:
Initial Electronic Security Group
Acquiror:
United Technologies Corp.
(the electronic security division of Rentokil Initial plc)
Advised Rentokil Initial on the sale of its electronic security division to United Technologies Corp.
19-Mar-07
$5.5 billion
Target:
The ServiceMaster Company
Acquiror:
Clayton, Dubilier & Rice
Provided fairness opinion to the Board of Directors of The ServiceMaster Company, a diversified consumer services business whose brands include Terminix, TruGreen and American Home Shield, in connection with its sale to private equity firm Clayton, Dubilier & Rice
25-Jan-07
$3.3 billion
Target:
Cardinal Health, Inc., Pharmaceutical Technologies and Services division
Acquiror:
The Blackstone Group
Provided fairness opinion to the board of directors of Cardinal Health, Inc., a global company serving the health-care industry, on the sale of its Pharmaceutical Technologies and Services business, which provides outsourced services and proprietary technologies to the global pharmaceutical and biotechnology industries
21-Dec-06
$3.3 billion
Target:
Raytheon Aircraft Company
Acquiror:
Goldman Sachs Capital Partners / Onex Partners
Provided advisory services and fairness opinion to the board of directors of Raytheon Company, a market leader in the aerospace and defense industry, on the sale of its Raytheon Aircraft division, which offers aircrafts and services and the renowned Hawker and Beechcraft brand names
06-Nov-06
$4.2 billion
Target:
Kos Pharmaceuticals, Inc.
Acquiror:
Abbott Laboratories
Advised Kos Pharmaceuticals, Inc., a specialty pharmaceutical provider of cardiovascular and respiratory drugs, on its sale to Abbott Laboratories